PSMD9 and hypertriglyceridemia: In transgenic mice with pancreatic overexpression of the homologous of PSMD9, it has been shown that the increased dose of the PSMD9 protein is causing insulin deficiency and diabetes as well as hypertriglyceridemia [10].